Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Gene knockout of glycine transporter 1: characterization of the behavioral phenotype.

Tsai G, Ralph-Williams RJ, Martina M, Bergeron R, Berger-Sweeney J, Dunham KS, Jiang Z, Caine SB, Coyle JT.

Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8485-90. Epub 2004 May 24.

2.

Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels.

Martina M, Gorfinkel Y, Halman S, Lowe JA, Periyalwar P, Schmidt CJ, Bergeron R.

J Physiol. 2004 Jun 1;557(Pt 2):489-500. Epub 2004 Apr 2.

3.

Altered mnemonic functions and resistance to N-METHYL-d-Aspartate receptor antagonism by forebrain conditional knockout of glycine transporter 1.

Singer P, Yee BK, Feldon J, Iwasato T, Itohara S, Grampp T, Prenosil G, Benke D, Möhler H, Boison D.

Neuroscience. 2009 Jun 30;161(2):635-54. doi: 10.1016/j.neuroscience.2009.03.056. Epub 2009 Mar 28.

4.

Modulation of N-methyl-D-aspartate receptor function by glycine transport.

Bergeron R, Meyer TM, Coyle JT, Greene RW.

Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15730-4.

5.
6.

Sustained saturating level of glycine induces changes in NR2B-containing-NMDA receptor localization in the CA1 region of the hippocampus.

Imamura Y, Ma CL, Pabba M, Bergeron R.

J Neurochem. 2008 Jun 1;105(6):2454-65. doi: 10.1111/j.1471-4159.2008.05324.x.

7.

Reduced glycine transporter type 1 expression leads to major changes in glutamatergic neurotransmission of CA1 hippocampal neurones in mice.

Martina M, B-Turcotte ME, Halman S, Tsai G, Tiberi M, Coyle JT, Bergeron R.

J Physiol. 2005 Mar 15;563(Pt 3):777-93. Epub 2005 Jan 20.

8.

Enhancement of the NMDA receptor function by reduction of glycine transporter-1 expression.

Gabernet L, Pauly-Evers M, Schwerdel C, Lentz M, Bluethmann H, Vogt K, Alberati D, Mohler H, Boison D.

Neurosci Lett. 2005 Jan 3;373(1):79-84.

PMID:
15555781
9.

Modulation of sensorimotor gating in prepulse inhibition by conditional brain glycine transporter 1 deletion in mice.

Singer P, Boison D, Möhler H, Feldon J, Yee BK.

Eur Neuropsychopharmacol. 2011 May;21(5):401-13. doi: 10.1016/j.euroneuro.2010.06.014. Epub 2010 Jul 19.

10.

Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.

Depoortère R, Dargazanli G, Estenne-Bouhtou G, Coste A, Lanneau C, Desvignes C, Poncelet M, Heaulme M, Santucci V, Decobert M, Cudennec A, Voltz C, Boulay D, Terranova JP, Stemmelin J, Roger P, Marabout B, Sevrin M, Vigé X, Biton B, Steinberg R, Françon D, Alonso R, Avenet P, Oury-Donat F, Perrault G, Griebel G, George P, Soubrié P, Scatton B.

Neuropsychopharmacology. 2005 Nov;30(11):1963-85.

11.

Severe impairment of NMDA receptor function in mice carrying targeted point mutations in the glycine binding site results in drug-resistant nonhabituating hyperactivity.

Ballard TM, Pauly-Evers M, Higgins GA, Ouagazzal AM, Mutel V, Borroni E, Kemp JA, Bluethmann H, Kew JN.

J Neurosci. 2002 Aug 1;22(15):6713-23.

12.

Glycine transporter 1 modulates GABA release from amacrine cells by controlling occupancy of coagonist binding site of NMDA receptors.

Rozsa E, Vigh J.

J Neurophysiol. 2013 Sep;110(6):1393-403. doi: 10.1152/jn.00193.2013. Epub 2013 Jun 26.

13.

Disruption of glycine transporter 1 restricted to forebrain neurons is associated with a procognitive and antipsychotic phenotypic profile.

Yee BK, Balic E, Singer P, Schwerdel C, Grampp T, Gabernet L, Knuesel I, Benke D, Feldon J, Mohler H, Boison D.

J Neurosci. 2006 Mar 22;26(12):3169-81.

14.

Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter-1 (GlyT1).

Manahan-Vaughan D, Wildförster V, Thomsen C.

Eur J Neurosci. 2008 Oct;28(7):1342-50. doi: 10.1111/j.1460-9568.2008.06433.x.

PMID:
18973561
15.

Taurine potentiates presynaptic NMDA receptors in hippocampal Schaffer collateral axons.

Suárez LM, Solís JM.

Eur J Neurosci. 2006 Jul;24(2):405-18. Epub 2006 Jul 12.

PMID:
16836643
16.

Inhibitors of GlyT1 affect glycine transport via discrete binding sites.

Mezler M, Hornberger W, Mueller R, Schmidt M, Amberg W, Braje W, Ochse M, Schoemaker H, Behl B.

Mol Pharmacol. 2008 Dec;74(6):1705-15. doi: 10.1124/mol.108.049312. Epub 2008 Sep 24. Erratum in: Mol Pharmacol. 2009 Jan;75(1):258.. Amberg, Martin Schmidt Willi [corrected to Schmidt, Martin]; Amberg, Martin Schmidt Willi [corrected to Amberg, Willi].

17.

Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition.

Gomeza J, Hülsmann S, Ohno K, Eulenburg V, Szöke K, Richter D, Betz H.

Neuron. 2003 Nov 13;40(4):785-96. Erratum in: Neuron. 2004 Feb 19;41(4):675.

18.

Increased hippocampal glycine uptake and cognitive dysfunction after peripheral nerve injury.

Kodama D, Ono H, Tanabe M.

Pain. 2011 Apr;152(4):809-17. doi: 10.1016/j.pain.2010.12.029. Epub 2011 Feb 3.

PMID:
21295405
19.
20.

D-aspartate prevents corticostriatal long-term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801.

Errico F, Rossi S, Napolitano F, Catuogno V, Topo E, Fisone G, D'Aniello A, Centonze D, Usiello A.

J Neurosci. 2008 Oct 8;28(41):10404-14. doi: 10.1523/JNEUROSCI.1618-08.2008.

Items per page

Supplemental Content

Write to the Help Desk